Status:
COMPLETED
Biological Markers to Identify Early Sepsis and Acute Lung Injury
Lead Sponsor:
Chimei Medical Center
Conditions:
Sepsis
Acute Lung Injury
Eligibility:
All Genders
18+ years
Brief Summary
There are no clear markers to identify sepsis and acute lung injury at early stage in clinical settings which would result in improved survival of the patients. In collaboration with the research team...
Eligibility Criteria
Inclusion
- Meet diagnostic criteria of ≧2 SIRS or acute lung injury.
- Get agreement of patient's attending physician and inform consent form patient or family.
Exclusion
- Use Antibiotics over 24 hrs（only SIRS group）.
- Active bleeding.
- Pregnancy.
- Active Cancer (refer to malignancy which is recently diagnosed, under treatment, or relapsed)
- VS or Subject or Family refuse
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00825357
Start Date
September 1 2006
End Date
August 1 2011
Last Update
January 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Intensive Care Medicine; Chi Mei Medical Center
Tainan, Taiwan